CAS 361440-67-7 Kemurnian >98,5% (HPLC) Gambar Unggulan Pabrik

CAS 361440-67-7 Kemurnian >98,5% (HPLC) Pabrik

Katrangan singkat:

(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]heksana-2-Asam Karboksilat tert-Butil Ester

CAS: 361440-67-7

Kemurnian: >98,5% (HPLC)

Penampilan: bubuk putih

Penengah API (CAS: 361442-04-8)

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Ruifu Chemical Supply Related Intermediates
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]heksana-2-Asam Karboksilat tert-Butil Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7

Sifat Kimia:

Jeneng Kimia	(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]heksana-2-Asam Karboksilat tert-Butil Ester
sinonim	N-Boc-L-cis-4,5-Methanoprolineamide;N-Boc-cis-4,5-Methano-L-Prolinamide;tert-Butyl (1S,3S,5S)-3-Carbamoyl-2-Azabicyclo[3.1.0]heksana-2-Carboxylate
Nomer CAS	361440-67-7
Nomer CAT	RF-PI1990
Status Simpenan	Ing Simpenan, Skala Produksi Nganti Ton
Formula Molekul	C11H18N2O3
Bobot Molekul	226.27
Titik didih	388,9 ± 21,0 ℃
Kapadhetan	1.228
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Bubuk Putih
Kemurnian / Metode Analisis	> 98,5% (HPLC)
Mundhut ing Pangatusan	<0,50%
Sisa ing Ignition	<0,20%
Impurities individu	<1.00%
Total Impurities	<1,50%
Test Standar	Standar Perusahaan
Panggunaan	Penengah API (CAS: 361442-04-8)

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan

Kaluwihan:

FAQ:

Aplikasi:

(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]heksana-2-Carboxylic Acid tert-Butyl Ester (CAS: 361440-67-7) minangka perantara API (CAS: 361442 -04-8).(CAS: 361442-04-8) minangka hypoglycemic oral (obat antidiabetes) saka kelas inhibitor dipeptidyl peptidase-4 (DPP-4).Pangembangan awal mung dening Bristol-Myers Squibb;ing 2007 AstraZeneca gabung karo Bristol-Myers Squibb kanggo ngembangaken senyawa final lan kolaborasi ing marketing saka tamba.Ing wulan Juni 2008, diumumake manawa Onglyza bakal dadi jeneng dagang sing bakal dipasarake.API (CAS: 361442-04-8) digunakake minangka monoterapi utawa ing kombinasi karo obat liya kanggo perawatan diabetes jinis 2.Diserep kanthi cepet sawise administrasi oral lan duwe profil farmakokinetik sing cocog karo dosis sapisan dina.Iki nduweni peran kanthi nyegah degradasi GLP-l.GLP-I minangka hormon sing diprodhuksi sacara alami ing usus sawise mangan.